Private company

Decheng Capital Global Life Sciences Fund IV, L.P.

Limited partnership based in 长宁区, Cayman Islands. Summary from the record

Last updated Oct 21, 2026.

Overview

Headquarters长宁区, China²
Legal formexempted limited partnership²
Kind of organizationLimited partnership²
LEI655600UQIMUV0MLAKN36²
StatusActive²
LEI statusLapsed (not renewed)²
Registered addressP.O. Box 309, Ugland House, KY1-1104 大开曼岛, Cayman Islands²
Registered withGeneral Registry, MC-109091²

See how the biggest companies compare on our leaderboards

Corporate structure

Decheng Capital Global Life Sciences Fund IV, L.P. sits at the top of its group. 4 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Decheng Capital Global Life Sciences Fund IV, L.P. 长宁区, China
- Aardvark Therapeutics, Inc. Stake · San Diego, California
- CG Oncology, Inc. Stake · Dallas, Texas
- Upstream Bio, Inc. Stake · Waltham, Massachusetts

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.

Stakes it holds

Decheng Capital Global Life Sciences Fund IV, L.P. has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).

Upstream Bio, Inc.SCHEDULE 13G/A Feb 14, 2025 to May 15, 2026³
Aardvark Therapeutics, Inc.SCHEDULE 13G Feb 24, 2025⁴
CG Oncology, Inc.SCHEDULE 13G/A Feb 8, 2024 to Feb 14, 2025⁵

Sources

The numbers on this page point here. Each one links to the record it came from.